Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis
The COVID-19 pandemic is caused by the SARS CoV-2 virus and can lead to severe lung damage and hyperinflammation. In the context of COVID-19 infection, inflammation-induced degradation of the glycocalyx layer in endothelial cells has been demonstrated. Syndecan-1 (SDC-1) is an established parameter...
Guardado en:
Autores principales: | Richard Vollenberg, Phil-Robin Tepasse, Kevin Ochs, Martin Floer, Markus Strauss, Florian Rennebaum, Iyad Kabar, Alexandros Rovas, Tobias Nowacki |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8a37347b50894411b5e0478c0ef79181 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19
por: Dong Zhang, et al.
Publicado: (2021) -
Protection and rebuilding of the endothelial glycocalyx in sepsis – Science or fiction?
por: Carolin Christina Drost, et al.
Publicado: (2021) -
Intramuscular Exposure to a Lethal Dose of Ricin Toxin Leads to Endothelial Glycocalyx Shedding and Microvascular Flow Abnormality in Mice and Swine
por: Anita Sapoznikov, et al.
Publicado: (2021) -
Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
por: Phil-Robin Tepasse, et al.
Publicado: (2021) -
Vascular Dysfunction in Malaria: Understanding the Role of the Endothelial Glycocalyx
por: Margaret A. Bush, et al.
Publicado: (2021)